Kistler Peter M, Obeyesekere Manoj N
Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.
Aust Fam Physician. 2007 Jul;36(7):500-5.
Cardiac arrhythmias may present with palpitations, chest pain, shortness of breath, dizziness and syncope. Diagnosis may be complicated by an inability to document the arrhythmia particularly when symptoms are infrequent and short lived.
This article aims to provide an overview of the pharmacological management of supraventricular tachycardia including atrial flutter and haemodynamically stable ventricular tachycardia. Management of atrial fibrillation is discussed in a companion article in this issue.
Antiarrhythmic medications are effective in reducing symptoms, however, side effects are frequent. Fortunately nonpharmacological strategies such as catheter ablation have evolved which offer long term cure in the majority of patients. However, despite technological advances, pharmacotherapy retains an important place in the therapeutic approach to cardiac arrhythmias in many patients. It is important to remember that pharmacological management should also address any underlying cardiac disease process.
心律失常可能表现为心悸、胸痛、呼吸急促、头晕和晕厥。心律失常难以记录，尤其是当症状不频繁且持续时间短时，这可能会使诊断变得复杂。
本文旨在概述室上性心动过速（包括心房扑动）和血流动力学稳定的室性心动过速的药物治疗。本期的另一篇相关文章讨论了心房颤动的治疗。
抗心律失常药物在减轻症状方面有效，然而，副作用很常见。幸运的是，诸如导管消融等非药物策略已经发展起来，在大多数患者中可实现长期治愈。然而，尽管有技术进步，药物治疗在许多患者的心律失常治疗方法中仍占有重要地位。重要的是要记住，药物治疗也应针对任何潜在的心脏疾病进程。
